The present study confirmed that there is a compensation factor that may be brought by the FGF21 protein because, in the overweight/obesity control group, the insulin level remains at 6.5 UI compared to 14.1 UI observed in the overweight/obesity experimental group. The gene discussed is INS; the disease is obesity disorder.